Login / Signup

Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial.

Samira KhaniSeyed Amir HejaziMehdi YaghoubiEhsan Sharifipour
Published in: The journal of headache and pain (2021)
The obtained results of this study revealed that magnesium could enhance the antimigraine properties of sodium valproate in combination therapy and reduce the required valproate dose for migraine prophylaxis.
Keyphrases
  • combination therapy
  • clinical trial
  • phase iii
  • double blind
  • study protocol
  • phase ii
  • single cell
  • stem cells
  • open label
  • locally advanced
  • mesenchymal stem cells
  • cell therapy
  • rectal cancer
  • replacement therapy